Skip to main content
TTrialFinderData
TrialFinderData is for informational purposes only and does not provide medical advice. Always talk to your doctor.

Cough Clinical Trials

Reviewed by TrialFinderData Editorial Team · Updated

4 recruiting trials for Cough. Eligibility criteria explained in plain English.

TrialFinderData lists 4 Cough clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.

Every phased trial in this set is Phase 3 (1 of the listed studies); the remaining records are observational or have no phase recorded on ClinicalTrials.gov.

Research is led by Cough Monitoring Medical Solutions (1), Charles University, Czech Republic (1), West Park Healthcare Centre (1), among the most active sponsors registered for these trials.

The most frequently studied intervention is C-mo System (device, 1 trial), followed by Non-pharmacological Cough control Therapy, Rengalin.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
4
Total Trials
4
Recruiting Now
1
Phase 3 Trials
4
Sponsors

Track Cough trials

Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.

Recruiting Trials

Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.

RECRUITINGNCT05989698

Validation of the C-mo System - Cough Monitoring

The goal of this clinical study is to validate C-mo System's ability to automatically detect and characterise cough, in patients over 2 years old with cough as a key or refractory...

Sponsor: Cough Monitoring Medical SolutionsEnrolling: 3008 locations
RECRUITINGNCT06201494

Prospective Multicentre Study on Symptoms in First-onset Bronchial Asthma in Children and Adolescents

Bronchial asthma may present with symptoms other than the commonly reported complaints (cough, chest tightness, shortness of breath and wheezing). Less common symptoms include...

Sponsor: Charles University, Czech RepublicEnrolling: 801 location
RECRUITINGNCT04767074

A Non-pharmacological Cough Control Therapy

Coughing affects almost all individuals with ILD leading to physical, psychological and social distress and prevents individuals from performing their activities of daily living,...

Sponsor: West Park Healthcare CentreEnrolling: 242 locations
RECRUITINGPhase 3NCT07171099

Efficacy and Safety of Rengalin in the Treatment of ARVI Cough in Children

The goal of this clinical trial is to evaluate the efficacy and safety of liquid dosage form of Rengalin in the treatment of cough in acute viral upper respiratory tract...

Sponsor: Materia Medica HoldingEnrolling: 26420 locations

Frequently Asked Questions

There are currently 4 clinical trials for Cough, with 4 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.

To join a clinical trial for Cough, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.

Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 1 Phase 3 trials for Cough, representing treatments closest to potential FDA approval.

Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.

Sources: ClinicalTrials.gov, FDA
Last updated:

Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.